Spiramycin renaissance.
Rubinstein
E
E
Unit of Infectious Diseases, Chaim Sheba Medical Center, Tel Aviv University School of Medicine, Tel-Hashomer, Israel.
Keller
N
N
D000284:Administration, Oral; D000900:Anti-Bacterial Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000382:microbiology; D015572:Spiramycin / Q000493:pharmacokinetics / Q000627:therapeutic use*; D014018:Tissue Distribution
D000900:Anti-Bacterial Agents; D015572:Spiramycin